Navigation Links
Kiwa Bio-Tech Ships 2,700 Tons of Bio-feed in One Month
Date:10/2/2007

BEIJING and CLAREMONT, Calif., Oct. 2 /PRNewswire-FirstCall/ -- Kiwa Bio-Tech Products Group Corporation (OTC Bulletin Board: KWBT) today announced that the Tianjin Kiwa Feed Limited Liability Company, located in Wuqing District in Tianjin, shipped 2,700 tons of animal feed during the month of September.

Mr. Wei Li, Chairman and CEO of Kiwa, stated, "We are pleased with the growth in volume of Kiwa's bio-feed products to approximately 7,550 tons during the third quarter compared to approximately 5,000 for the first two quarters of the year. We anticipate continued growth of the feed products will be complemented by sales of organic fertilizers from the Shandong factory."

Kiwa recently announced that:

-- it had completed the first stage of upgrading the manufacturing

facility for its fertilizer products,

-- had registered products with the Shandong Provincial Soil and

Fertilizer Station and

-- had six products certified as organic by the China Green Food

Association of the Agriculture Ministry

Tianjin Kiwa Feed is jointly owned by Kiwa and Tianjin Challenge Feed Co. Tianjin Challenge Feed Co. is partially owned by and has built a large sales network, in part, due to its relations with China Challenge Group. Its products are sold in Shandong, North China and Northeast China.

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please visit the Company's website at http://www.kiwabiotech.com.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company's reports filed with the Securities and Exchange Commission. The forward-looking information provided herein represents the Company's estimates as of the date of the press release, and subsequent events and developments may cause the Company's estimates to change. The Company specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company's estimates of its future financial performance as of any date subsequent to the date of this press release.

Contact:

Kiwa Bio-Tech Products Group Corporation

Yvonne Wang

(626) 715-5855

kiwabiotech@gmail.com

Robert Schechter

Equity Communications

212-499-6809 direct 646 234 3624

ir4kiwa@hotmail.com


'/>"/>
SOURCE Kiwa Bio-Tech Products Group Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Industry Veterans take a look back from 2025: Bio-Technology, and Bio-Informatics are the focus
2. Big pharma seeks Wisconsin biotech partnerships
3. Dont forget building relationships when building business
4. 40 Midwest biotech organizations to explore Japanese partnerships
5. Meriter IT team builds project performance through internal relationships
6. Blooming partnerships
7. Enhancing Relationships with Investors
8. Avoid Trading Tech Relationships Like Pokmon Cards
9. Quantity versus Quality: Effective E-Marketing Relationships
10. EraGen Biosciences Ships SARS Diagnostic Test in Record Time
11. Milwaukee could be wireless in 18 months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... is pleased to announce the launch of their brand, UP4™ Probiotics, into Target ... over 35 years, is proud to add Target to its list of well-respected ...
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
Breaking Biology Technology:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:3/31/2016)... Florida , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange ... potential users of its soon to be launched online ... ( https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential ... use of DNA technology to an industry that is ...
Breaking Biology News(10 mins):